Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass.
about
Tranexamic acid: from trauma to routine perioperative useWhat dose of tranexamic acid is most effective and safe for adult patients undergoing cardiac surgery?Pharmacokinetics of tranexamic acid in neonates and infants undergoing cardiac surgery.Pharmacokinetic modeling of tranexamic acid for patients undergoing cardiac surgery with normal renal function and model simulations for patients with renal impairment.Protocol for a pilot, randomised, double-blinded, placebo-controlled trial of prophylactic use of tranexamic acid for preventing postpartum haemorrhage (TAPPH-1).Effect of cardiopulmonary bypass on cytochrome P450 enzyme activity: implications for pharmacotherapy.Is tranexamic acid exposure related to blood loss in hip arthroplasty? A pharmacokinetic-pharmacodynamic study.Effects of Tranexamic Acid Based on its Population Pharmacokinetics in Pediatric Patients Undergoing Distraction Osteogenesis for Craniosynostosis: Rotational Thromboelastometry (ROTEM) Analysis
P2860
Q28083660-A6A99887-F1E7-4092-9C76-F081DE42F843Q38503969-A0F0CACB-7AE4-49E0-B578-FE62163D9489Q38937171-EFF50CD3-7388-452C-9FD6-79544DA7D296Q41371870-68B19517-53D3-4027-A6A0-619922EF657CQ42650009-391207B5-0C8F-42C2-9282-C052311BD392Q47288317-34314870-3F27-4DE6-BD11-C2D114D0A6C2Q47386905-7A8AB6A9-E6EE-4F74-82C1-BB18A076DB2FQ56262580-4F916FBD-558F-4002-B9E0-21085CFCB7B6
P2860
Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Population pharmacokinetics of ...... y with cardiopulmonary bypass.
@en
Population pharmacokinetics of ...... y with cardiopulmonary bypass.
@nl
type
label
Population pharmacokinetics of ...... y with cardiopulmonary bypass.
@en
Population pharmacokinetics of ...... y with cardiopulmonary bypass.
@nl
prefLabel
Population pharmacokinetics of ...... y with cardiopulmonary bypass.
@en
Population pharmacokinetics of ...... y with cardiopulmonary bypass.
@nl
P2093
P356
P1476
Population pharmacokinetics of ...... ry with cardiopulmonary bypass
@en
P2093
P304
P356
10.1093/BJA/AET255
P407
P577
2013-07-23T00:00:00Z